AAFMAA Wealth Management & Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-18,615
Closed -$1.17M 96
2026
Q1
$1.17M Sell
18,615
-349
-2% -$27.9K 0.45% 50
2025
Q4
$1.81M Buy
18,964
+1,952
+11% +$191K 0.71% 39
2025
Q3
$1.66M Sell
17,012
-219
-1% -$22.7K 0.66% 44
2025
Q2
$1.85M Sell
17,231
-7,118
-29% -$720K 0.77% 35
2025
Q1
$2.46M Sell
24,349
-5,289
-18% -$533K 1.12% 19
2024
Q4
$2.65M Sell
29,638
-3,094
-9% -$272K 1.16% 21
2024
Q3
$2.74M Buy
32,732
+3,077
+10% +$243K 1.21% 21
2024
Q2
$2.28M Sell
29,655
-221
-0.7% -$16.2K 1.12% 24
2024
Q1
$2.05M Buy
29,876
+9,780
+49% +$629K 1.12% 27
2023
Q4
$1.16M Buy
+20,096
New +$1.07M 0.66% 44

Other funds holding BSX

AAFMAA Wealth Management & Trust's BSX Position: Q2 2026 in Review

AAFMAA Wealth Management & Trust sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 18,615 shares — an estimated $1.17M sold.

AAFMAA Wealth Management & Trust first reported a position in BSX in Q4 2023 and held it in 10 quarters. The position peaked at $2.74M in Q3 2024. 303 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • AAFMAA Wealth Management & Trust reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • AAFMAA Wealth Management & Trust sold 18,615 Boston Scientific shares in Q2 2026, an estimated $1.17M.
  • AAFMAA Wealth Management & Trust first reported a position in Boston Scientific in Q4 2023 and held it in 10 quarters.
  • AAFMAA Wealth Management & Trust's Boston Scientific position peaked at $2.74M in Q3 2024.
  • 303 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on AAFMAA Wealth Management & Trust's 13F filing for Q2 2026, filed 8 Jul 2026.